Mesothelioma Attorney

Jury Awards $12.1 Million to Estate of 83-Year-Old Korean War Veteran

June 18, 2021 | Throneberry Law Group

In a recently decided Ohio mesothelioma lawsuit, a jury awarded the estate of an 83-year-old Korean War Veteran $12.1 million in compensatory and punitive damages. The jury awarded the veteran’s estate this amount after hearing and deliberating on the details of the veteran’s decades-long asbestos exposure and his ensuing diagnosis and death from malignant mesothelioma. At first, the jury had awarded the plaintiff compensatory damages amounting to $6.1 million. The judge then decided to add another $6 million in punitive damages against John Crane, Inc.

The war veteran worked in the stockroom at the Pfaudler Co. plant in Elyria, Ohio, for more than four decades. He started working at the Pfaudler Co. plant after his service in Korea. While working at Pfaudler, the veteran was responsible for preparing shipments of specialized glass-coated steel bowls used in chemical and pharmaceuticals manufacturing. Every week, he would spend hours cutting asbestos-contaminated rope using a band saw. Because the material was asbestos-contaminated, cutting it with a band saw led to the spread of asbestos particles into the air, which he then inhaled.

According to reports, the veteran was a hard-working man who always did what he was told to do at work. Unfortunately, neither he nor his fellow employees were ever informed of the hazards of the product they were handling because Pfaudler was in the dark. Pfaudler was never warned about the asbestos-contaminated rope, and the evidence presented at trial proved this fact. Crane Packing Co., now formally known as John Crane Inc., the material’s manufacturer, knew that the material had a high concentration of blue crocidolite asbestos, but never warned Pfaudler of the material’s potential danger or advised the plant on proper handling. The material’s manufacturer always advertised the material as ‘completely non-toxic.’ However, once Pfaudler realized that the material was toxic – an entire three years before John Crane issued any form of public warning – the company stopped using it. Unfortunately, by then, it was late for the war veteran, as he had already been exposed to asbestos for many years.

Massachusetts Attorney General Sues Four Companies Over Illegal Asbestos Work

May 29, 2021 | Throneberry Law Group

Massachusetts’ attorney general recently filed a lawsuit against four companies that the state’s chief prosecutor claims improperly removed, transported, and stored asbestos during an abatement project at city YMCA building, which hosts daycare programs and housing. The lawsuit is another in a string of priority enforcement efforts brought by the state’s attorney general to bring asbestos enforcement to bear and is an important part of the office’s effort to protect vulnerable communities in the state and hold wrongdoers accountable.

“We allege that the defendants’ reckless disregard of basic workplace procedures and failure to take proper precautions put the health and safety of workers, building occupants, and the surrounding community at risk,” said Attorney General Maura Healey. “Those who deal with asbestos have a duty to do so in a safe and legal way to protect workers and the public from the serious harms of asbestos exposure, and we will take action against those who don’t comply.”

According to the lawsuit, filed in Suffolk Superior Court, Ray Services Inc., an asbestos abatement company, O’Reilly, Talbot, & Okun Associates, Inc., an environmental consulting company, Allegrone Construction Co., a general contractor, and Service Transport Group, a transportation company, each violated the Massachusetts’ Clean Air Act and corresponding regulations. Defendant Ray Services Inc. allegedly removed dry, spray-on fire-proofing material containing asbestos by scraping the material off ceiling ducts, pipes, and beams in unoccupied classrooms in the building.

North Carolina Firefighters Lobby for Presumptive Coverage of Mesothelioma and Other Cancers

May 28, 2021 | Throneberry Law Group

The fight for presumptive coverage of cancer continues as North Carolina remains the only state in the country that does not extend this right to firefighters who put their lives on the line each time they suit up and are potentially exposed to a whole host of cancer-causing carcinogens. While the state does extend certain benefits to surviving family members of firefighters who pass away from one of four listed cancers, North Carolina does not pay for medical coverage of the affected firefighter during his or her lifetime, which can leave the victim and his or her family with extraordinary medical bills.

Across the state, North Carolina firefighter groups are lobbying state lawmakers to expand workers’ compensation benefits for firefighters who contract certain forms of cancer and for that diagnosis to be presumed to have been caused due to exposure to toxic chemicals while in the line of service. In 2019, the North Carolina house of representatives passed one such bill that would label nine forms of cancer, including mesothelioma, as occupational diseases and would have provided medical coverage to those affected under North Carolina’s existing Workers’ Compensation Act.

However, the state senate ultimately blocked the bill and has maintained that it as a chamber is opposed to expanding workers’ compensation benefits in the state. Despite the changing situational realities that firefighters face when they rush into burning buildings to save those trapped inside, North Carolina legislators continue to put up barriers to benefits that would help ensure that brave first responders have their healthcare needs taken care of when they receive a devastating cancer diagnosis.

One of Nation’s Largest Railroad Companies Sues Health Clinic Providing Aid to Asbestos Victims

May 17, 2021 | Throneberry Law Group

One of the country’s largest railroad companies recently made headlines when it filed a lawsuit against a Montana health clinic that provides aid to asbestos and mesothelioma cancer victims harmed by a now shuttered vermiculite mine, and the railway company itself for the two entities’ roles in spreading carcinogenic asbestos fibers across the area. The company, BNSF Railway, is suing the Center for Asbestos Related Disease, located in Libby, Montana, claiming that the clinic is defrauding the federal government by conducting what the railway calls unnecessary tests and is relying on supposedly inaccurate radiological studies to diagnose asbestos victims in the town and surrounding area.

Though only made public recently, the suit was originally filed back in 2019. The claim asked the federal government to investigate and prosecute the Center for Asbestos Related Disease for fraud against the taxpayer. Fortunately, the federal government declined to intervene on behalf of BNSF Railway, leaving the company to carry the claim on itself under the federal whistleblower statute that allows private entities to bring claims on behalf of the government and receive a portion of any recovery for itself.

The Center for Asbestos Related Disease is one of the few healthcare providers in the country that commits itself to study the health effects of the particular form of asbestos found in the vermiculite mines of Libby. To that end, the Center for Asbestos Related Disease is the leading provider of asbestos-related diagnoses and healthcare to the residents of the small town which found itself at the epicenter of one of the worst environmental cleanups in the United States.

Court Allows Mesothelioma Cancer Lawsuit to Proceed Against Retailer

May 9, 2021 | Throneberry Law Group

A New York state court recently issued an important ruling in an asbestos cancer lawsuit preventing one of the defendants from attempting to have itself removed from the case and potentially escape liability for its role in the victim’s cancer diagnosis. With the court’s ruling, defendant retailer Lot Less will remain as a defendant to the case while the plaintiff proceeds with the information gathering phase of the litigation in order to establish exactly what the business knew about the safety of the products it sold to consumers like the victim in this case.

According to the mesothelioma cancer lawsuit, filed in the Supreme Court of New York County in 2018, the now deceased plaintiff developed malignant mesothelioma cancer from years of using Johnson & Johnson’s Baby Powder, which was contaminated with deadly asbestos fibers. The plaintiff contends that not only Johnson & Johnson should be held liable for manufacturing the carcinogenic talc-based product, but also retailer Lot Less for selling the product to consumers like the victim. Other defendants named in the case included Bristol-Meyers Squibb, Cyprus Amax Minerals Company, and Whittaker Clark & Daniels.

In its motion for summary judgment, Lot Less argued that the family of the victim, who brought the suit on her behalf, had not yet proven that the Johnson & Johnson product in question actually contained asbestos. Further, the company argued that sellers of defective products generally have an implied right to indemnification, that is that they cannot be held liable for legally selling a product that a manufacturer produced. Fortunately for the plaintiff, the judge hearing the case determined that it would be premature to remove Lot Less from the case since the underlying liability had not yet been established.

Mississippi Talc Labeling Lawsuit Able to Proceed With State’s Supreme Court Refusal to Toss Claim

April 30, 2021 | Throneberry Law Group

A long running lawsuit brought by the state of Mississippi against pharmaceutical and cosmetics giant Johnson & Johnson may proceed, after the state supreme court refused to side with the company in its bid to toss the claim involving allegations that it violated state laws concerning labeling of its talc-based products. Specifically, the lawsuit brought by Mississippi’s attorney general claimed that Johnson & Johnson failed to disclose possible health risks associated with using the company’s Baby Powder and Shower to Shower talcum powder products which the company faces an avalanche of litigation in federal and state courts across the country.

According to the lawsuit, filed in Hinds County Chancery Court in 2014, Johnson & Johnson violated Mississippi’s Consumer Protection Act when the company failed to include labels on its talcum powder products displaying a warning of the possible links between using talc-based products and developing ovarian cancer. The state’s attorney general’s lawsuit sought an injunction to force Johnson & Johnson to include warnings on talcum powder product labels and enforce violations with fines up to $10,000.

After the state filed its preliminary lawsuit in county court, Johnson & Johnson asked the court to toss out the lawsuit. After the chancery court refused to do so in December 2018, the company appealed to a state appellate court to do the same, but was met with a similar denial. Johnson & Johnson subsequently went to the state’s highest court for yet another dismissal, arguing that labeling requirements on its cosmetics products are preempted by federal laws and the state therefore had no authority to require the company include the types of warning labels the matter pertained to.

Widow’s Mesothelioma Cancer Lawsuit Goes on against Conwed Lo-Tone Ceiling Tiles & Mineral Boards Despite COVID-19

April 18, 2021 | Throneberry Law Group

The effects of COVID-19 have been felt across nearly every facet of life in America, and the courts have certainly been no exception. With health and safety protocols limiting in-person gatherings, many individuals seeking justice through the courts have had their hearings and trials seemingly inevitably delayed until the United States is able to bring the virus under control in order to resume our way of life. However, some have been fortunate in that their cases have been able to continue with relatively modest delay, as in the case of a Minnesota factory worker whose trial is finally scheduled to take place in May 2021.

According to the asbestos cancer lawsuit, filed in Ramsey County District Court in 2019, the now deceased plaintiff was diagnosed with mesothelioma cancer in December 2018, and caused due to his exposure to carcinogenic asbestos fibers from his years of working the the Conwed Corporation’s mineral board plant in Cloquet, Minn. According to media reports, the city of Cloquet has a mesothelioma cancer death rate that is 36% higher than anywhere else in the state of Minnesota, and the rate of diagnosis is up to 70 times higher than the average. The report goes on to state that lung cancer screenings have shown that at least 30% of Condwed’s former employees surveyed have developed mesothelioma.

Mesothelioma is a rare and deadly form of cancer that usually affects vital organs such as the lungs, heart, and abdominal cavity. Developing the disease is directly associated with exposure to asbestos, a mineral that was once used in a variety of commercial, industrial, and military applications for its heat resistant properties and ability to be molded to fit a variety of uses. Conwed Corporation allegedly used asbestos in the construction of its mineral board products at the Cloquet plant from 1958 until 1974, the time period during which the deceased plaintiff was employed at the facility.

California Appeals Court Upholds Asbestos Cancer Verdict Against J-M Manufacturing

April 10, 2021 | Throneberry Law Group

A California appeals court recently upheld a substantial multimillion dollar jury verdict awarded to a husband and wife who claimed that the defendant caused the husband’s rare and deadly form of cancer from exposure to asbestos containing products manufactured by the company. In their verdict in favor of the plaintiffs, the California state jury awarded the husband over $14 million for his economic damages, as well as his pain and suffering, and an additional $1 million to his wife for her loss of consortium. The defendant, J-M Manufacturing, appealed the jury’s verdict in the hopes of having the verdict and the awards tossed.

According to the asbestos cancer lawsuit, filed in Los Angeles County Superior Court in 2018, the husband plaintiff was employed as a construction worker and supervision during the 1970s and 1980s. During that time, according to the lawsuit, he was frequently exposed to asbestos fibers in cement pipes manufactured and sold by J-M Manufacturing. As a result of this exposure to asbestos containing products over nearly two decades, the plaintiff developed a rare and deadly form of lung cancer called mesothelioma.

After a trial spanning October and November 2018, the Los Angeles County jury awarded the plaintiff and his wife over $15 million in compensatory damages for their past and future medical bills, pain and suffering, and loss of consortium. Additionally, the jury saw fit to award the plaintiffs an additional $15 million in punitive damages, which are a special type of award handed down in circumstances where it can be established that a defendant acted with an much more egregious level of negligence.

National Association of Distinguished Counsel Recognizes Attorney Michael Throneberry

March 30, 2021 | Throneberry Law Group

Michael Throneberry, of Throneberry Law Group, has been selected to the 2021 list as a member of the Nation’s Top One Percent by the National Association of Distinguished Counsel. NADC is an organization dedicated to promoting the highest standards of legal excellence. Its mission is to objectively recognize the attorneys who elevate the standards of the Bar and provide a benchmark for other lawyers to emulate.

Members are thoroughly vetted by a research team, selected by a blue ribbon panel of attorneys with podium status from independently neutral organizations, and approved by a judicial review board as exhibiting virtue in the practice of law. Due to the incredible selectivity of the appointment process, only the top one percent of attorneys in the United States are awarded membership in NADC. This elite class of advocates consists of the finest leaders of the legal profession from across the nation.

Norwegian biotech company’s immunotherapy drug shows promise for mesothelioma patients who undergo chemotherapy

March 27, 2021 | Throneberry Law Group

A Norwegian biotechnology company recently announced that the 21-month followup data from its clinical stage immunotherapy trials revealed promising results for mesothelioma patients who are also undergoing chemotherapy to treat their rare and deadly form of cancer caused by asbestos exposure. The results of the study show that at least half of the patients who took the company’s immuno-oncology drug while undergoing chemotherapy are still alive, compared to an average survival rate of just over a year for those who did not.

Targovax ASA’s phase I/II trial of its ONCOS-102 aims to assess the safety, immune activation and clinical efficacy of the drug taken in combination with a patient’s chemotherapy regimen compared to those who underwent the standard chemotherapy only. The study examined 31patients in total, with 20 receiving the ONCOS-102 immunotherapy drug which targets hard to kill mesothelioma tumor cells. “It is most encouraging that survival continues to track so well in the ONCOS-102-treated first line group,” said Targovax’s chief medical officer . “We have earlier seen and reported how ONCOS-102 drives profound remodeling of the tumor microenvironment. It is now becoming clear that this is translating into long-term survival benefit.”

Mesothelioma has a latency period of anywhere from 20 to 50 years, which means decades can pass after exposure to asbestos before doctors are able to make a diagnosis, leaving many patients with diminished treatment options. Oftentimes, surgery is not an option to kill mesothelioma tumors, and patients are left with only chemotherapy as an option, which can take a toll on the individual’s overall health.